Is OVID research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OVID. It does not provide personalized investment advice.

OVID (Ovid Therapeutics Inc. Common Stock) Stock Analysis - Financials

Ovid Therapeutics Inc. Common Stock (OVID) is a publicly traded Healthcare sector company. As of July 8, 2026, OVID trades at $2.61 with a market cap of $487.13M and a P/E ratio of 0.00. OVID moved -5.62% today. Year to date, OVID is +69.33%; over the trailing twelve months it is +637.97%. Its 52-week range spans $0.24 to $3.11. Analyst consensus is strong buy with an average price target of $5.60. Rallies surfaces OVID's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are OVID's key financials?

OVID financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. OVID recently traded at $2.61. Market cap is $487.13M. P/E ratio is 0.00. Revenue is $7.12M.

OVID Key Metrics

Key financial metrics for OVID
Metric	Value
Price	$2.61
Market Cap	$487.13M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$3.11
52-Week Low	$0.24
Volume	386.32K
Avg Volume	0
Revenue (TTM)	$7.12M
Net Income	$-24.17M
Gross Margin	0.00%

OVID Analyst Consensus

7 analysts cover OVID: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.60.

Common questions about OVID

What are OVID's key financials?: OVID financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. OVID recently traded at $2.61. Market cap is $487.13M. P/E ratio is 0.00. Revenue is $7.12M.
Is OVID research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OVID. It does not provide personalized investment advice.